These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 64656)

  • 21. Editorial: Drug therapy for prevention of arterial thrombosis.
    Sixma JJ
    Neth J Med; 1975; 18(4):121-4. PubMed ID: 1165829
    [No Abstract]   [Full Text] [Related]  

  • 22. [The difficult choice of antithrombotic therapy after bioprosthetic aortic valve implantation: aspirin, warfarin, or both?].
    Marullo AG; Iacò AL; Calafiore AM
    G Ital Cardiol (Rome); 2013 Apr; 14(4):246-7. PubMed ID: 23567764
    [No Abstract]   [Full Text] [Related]  

  • 23. Risk of stent thrombosis after lower-extremity endovascular revascularization: which is the optimal antithrombotic therapy and is early strenuous exercise safe?
    Ambrosetti M; Tozzi M; Piffaretti G; Barosi A; Caronno R; Poggio G; Castelli P
    Minerva Cardioangiol; 2008 Apr; 56(2):261-2. PubMed ID: 18319707
    [No Abstract]   [Full Text] [Related]  

  • 24. [Do all the patients with adult-onset diabetes mellitus need acetylsalicylic acid?].
    Lassila R
    Duodecim; 1999; 115(10):1174-7. PubMed ID: 11877857
    [No Abstract]   [Full Text] [Related]  

  • 25. Antithrombotic therapy for acute myocardial infarction: mechanisms and prevention of deep venous, left ventricular, and coronary artery thromboembolism.
    Chesebro JH; Fuster V
    Circulation; 1986 Nov; 74(5 Pt 2):III1-10. PubMed ID: 3533316
    [No Abstract]   [Full Text] [Related]  

  • 26. Primary antithrombotic prevention in carriers of antiphospholipid antibodies without systemic autoimmune disorders.
    Finazzi G
    Lupus; 2012 Jun; 21(7):747-50. PubMed ID: 22635221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (third of three parts).
    Genton E; Gent M; Hirsh J; Harker LA
    N Engl J Med; 1975 Dec; 293(25):1296-300. PubMed ID: 1102986
    [No Abstract]   [Full Text] [Related]  

  • 28. A novel synthetic inhibitor of factor Xa decreases early reocclusion and improves 24-h patency after coronary fibrinolysis in dogs.
    Abendschein DR; Baum PK; Verhallen P; Eisenberg PR; Sullivan ME; Light DR
    J Pharmacol Exp Ther; 2001 Feb; 296(2):567-72. PubMed ID: 11160645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prevention of acute thrombosis and embolism of the aortic bifurcation and the major arteries of the extremities].
    Ivashchenko VV
    Klin Khir (1962); 1991; (10):54-9. PubMed ID: 1774875
    [No Abstract]   [Full Text] [Related]  

  • 30. High-density lipoprotein as a modulator of platelet and coagulation responses.
    van der Stoep M; Korporaal SJ; Van Eck M
    Cardiovasc Res; 2014 Aug; 103(3):362-71. PubMed ID: 24891399
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Peripheral arterial revascularization: which antithrombotic agents?].
    Haulon S; Susen S; Koussa M; Jude B
    Arch Mal Coeur Vaiss; 2001 Nov; 94(11 Suppl):1278-84. PubMed ID: 11794970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aspirin in essential thrombocythemia: status quo and quo vadis.
    Griesshammer M; Bangerter M; van Vliet HH; Michiels JJ
    Semin Thromb Hemost; 1997; 23(4):371-7. PubMed ID: 9263354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Should one employ anticoagulants or platelet inhibitors in the long-term prophylaxis, with or without surgery, of arterial occlusive disease?].
    Breddin J; Hess H
    Med Welt; 1981 Sep; 32(37):1343-4. PubMed ID: 6795422
    [No Abstract]   [Full Text] [Related]  

  • 34. Combination antithrombotic therapies.
    Gurbel PA; Tantry US
    Circulation; 2010 Feb; 121(4):569-83. PubMed ID: 20124137
    [No Abstract]   [Full Text] [Related]  

  • 35. Thrombosis and neointima formation in vein grafts are inhibited by locally applied aspirin through endothelial protection.
    Torsney E; Mayr U; Zou Y; Thompson WD; Hu Y; Xu Q
    Circ Res; 2004 Jun; 94(11):1466-73. PubMed ID: 15117816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Use of acetylsalicylic acid in the prevention of re-occlusion following revascularization interventions. Results of a double-blind long term study].
    Ehresmann U; Alemany J; Loew D
    Med Welt; 1977 Jul; 28(26):1157-62. PubMed ID: 886967
    [No Abstract]   [Full Text] [Related]  

  • 37. Prevention and treatment of arterial thrombosis in pregnancy.
    Clark P; Greer IA
    Semin Thromb Hemost; 2003 Apr; 29(2):155-64. PubMed ID: 12709918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Animal models for arterial thrombolysis and prevention of reocclusion. Erythrocyte-rich versus platelet-rich thrombus.
    Gold HK; Yasuda T; Jang IK; Guerrero JL; Fallon JT; Leinbach RC; Collen D
    Circulation; 1991 Jun; 83(6 Suppl):IV26-40. PubMed ID: 2040069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The action of various drugs in the prevention of re-occlusion following Dotter's catheter disobliteration].
    Zeitler E
    Med Welt; 1976 Jul; 27(28):1377-80. PubMed ID: 785147
    [No Abstract]   [Full Text] [Related]  

  • 40. Management of thrombosis during pregnancy.
    Inbal A
    Isr Med Assoc J; 2002 Oct; 4(10):813-4. PubMed ID: 12389348
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.